|
1
|
Chow LQM: Head and neck cancer. N Engl J
Med. 382:60–72. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shield KD, Ferlay J, Jemal A,
Sankaranarayanan R, Chaturvedi AK, Bray F and Soerjomataram I: The
global incidence of lip, oral cavity, and pharyngeal cancers by
subsite in 2012. CA Cancer J Clin. 67:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chinn SB and Myers JN: Oral cavity
carcinoma: Current management, controversies, and future
directions. J Clin Oncol. 33:3269–3276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schindl M, Schoppmann SF, Ströbel T,
Heinzl H, Leisser C, Horvat R and Birner P: Level of Id-1 protein
expression correlates with poor differentiation, enhanced malignant
potential, and more aggressive clinical behavior of epithelial
ovarian tumors. Clin Cancer Res. 9:779–785. 2003.PubMed/NCBI
|
|
7
|
Sun W, Guo MM, Han P, Lin JZ, Liang FY,
Tan GM, Li HB, Zeng M and Huang XM: Id-1 and the p65 subunit of
NF-κB promote migration of nasopharyngeal carcinoma cells and are
correlated with poor prognosis. Carcinogenesis. 33:810–817. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin J, Guan Z, Wang C, Feng L, Zheng Y,
Caicedo E, Bearth E, Peng JR, Gaffney P and Ondrey FG: Inhibitor of
differentiation 1 contributes to head and neck squamous cell
carcinoma survival via the NF-kappaB/survivin and phosphoinositide
3-kinase/Akt signaling pathways. Clin Cancer Res. 16:77–87. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benezra R, Davis RL, Lockshon D, Turner DL
and Weintraub H: The protein Id: A negative regulator of
helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Perk J, Iavarone A and Benezra R: Id
family of helix-loop-helix proteins in cancer. Cancer. 5:603–614.
2005.PubMed/NCBI
|
|
11
|
Dong Z, Liu S, Zhou C, Sumida T, Hamakawa
H, Chen Z, Liu P and Wei F: Overexpression of Id-1 is associated
with tumor angiogenesis and poor clinical outcome in oral squamous
cell carcinoma. Oral Oncol. 46:154–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishimine M, Nakamura M, Mishima K, Kishi
M, Kirita T, Sugimura M and Konishi N: Id proteins are
overexpressed in human oral squamous cell carcinomas. J Oral Pathol
Med. 32:350–357. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao J, Wang S, Liu N and Tang X:
Correlation between the expression of Id-1 and
hyperthermia-associated molecules in oral squamous cell carcinoma.
J Clin Pathol. 66:758–763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lydiatt WM, Patel SG, O'Sullivan B,
Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head
and neck cancers-major changes in the American joint committee on
cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:122–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schoppmann SF, Schindl M, Bayer G, Aumayr
K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R and Birner P:
Overexpression of Id-1 is associated with poor clinical outcome in
node negative breast cancer. Int J Cancer. 104:677–682. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kyrgidis A, Tzellos TG, Kechagias N,
Patrikidou A, Xirou P, Kitikidou K, Bourlidou E, Vahtsevanos K and
Antoniades K: Cutaneous squamous cell carcinoma (SCC) of the head
and neck: Risk factors of overall and recurrence-free survival. Eur
J Cancer. 46:1563–1572. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu JM and Montgomery E: Classification and
pathology. Surg Clin North Am. 88:483–520. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ke J, Wu R, Chen Y and Abba ML: Inhibitor
of DNA binding proteins: Implications in human cancer progression
and metastasis. Am J Transl Res. 10:3887–3910. 2018.PubMed/NCBI
|
|
19
|
Li L, Wei X, Wu B, Xiao Y, Yin M and Yang
Q: siRNA-mediated knockdown of ID1 disrupts Nanog- and
Oct-4-mediated cancer stem cell-likeness and resistance to
chemotherapy in gastric cancer cells. Oncol Lett. 13:3014–3024.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Georgiadou D, Sergentanis TN, Sakellariou
S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T,
Lazaris AC, Patsouris E and Zografos GC: VEGF and Id-1 in
pancreatic adenocarcinoma: Prognostic significance and impact on
angiogenesis. Eur J Surg Oncol. 40:1331–1337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao ZR, Zhang ZY, Zhang H, Jiang L, Wang
MW and Sun XF: Overexpression of Id-1 protein is a marker in
colorectal cancer progression. Oncol Rep. 19:419–424.
2008.PubMed/NCBI
|
|
22
|
Li J, Li Y, Wang B, Ma Y and Chen P: Id-1
promotes migration and invasion of non-small cell lung cancer cells
through activating NF-κB signaling pathway. J Biomed Sci.
24:952017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu Y, Luo KJ, Wen J and Zhu ZH: Strong
expression of Id-1 in metastatic lymph nodes from esophageal
squamous cell carcinoma is associated with better clinical outcome.
J Thorac Dis. 10:5499–5507. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuen HF, Chan YP, Chan KK, Chu YY, Wong
ML, Law SY, Srivastava G, Wong YC, Wang X and Chan KW: Id-1 and
Id-2 are markers for metastasis and prognosis in oesophageal
squamous cell carcinoma. Br J Cancer. 97:1409–1415. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fidler IJ and Hart IR: Biological
diversity in metastatic neoplasms: Origins and implications.
Science. 217:998–1003. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Yin X, Zhang H, Sun G, Yang Y,
Chen J, Zhu X, Zhao P, Zhao J, Liu J, et al: Differential
expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic
sites in renal cell carcinoma. BMC Cancer. 19:3602019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire
V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, et al: Differential gene
and protein expression in primary breast malignancies and their
lymph node metastases as revealed by combined cDNA microarray and
tissue microarray analysis. Cancer. 100:1110–1122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Inari H, Suganuma N, Kawachi K, Yoshida T,
Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Yamanaka A, Masudo
K, et al: Expression of enhancer of zeste homolog 2 correlates with
survival outcome in patients with metastatic breast cancer:
Exploratory study using primary and paired metastatic lesions. BMC
Cancer. 17:1602017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Patel SG, Amit M, Yen TC, Liao CT,
Chaturvedi P, Agarwal JP, Kowalski LP, Ebrahimi A, Clark JR, Cernea
CR, et al: Lymph node density in oral cavity cancer: Results of the
international consortium for outcomes research. Br J Cancer.
109:2087–2095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tabatabaeifar S, Larsen MJ, Larsen SR,
Kruse TA, Thomassen M and Sørensen JA: Investigating a case of
possible field cancerization in oral squamous cell carcinoma by the
use of next-generation sequencing. Oral Oncol. 68:74–80. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soroceanu L, Murase R, Limbad C, Singer E,
Allison J, Adrados I, Kawamura R, Pakdel A, Fukuyo Y, Nguyen D, et
al: Id-1 is a key transcriptional regulator of glioblastoma
aggressiveness and a novel therapeutic target. Cancer Res.
73:1559–1569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong Z, Wei F, Zhou C, Sumida T, Hamakawa
H, Hu Y and Liu S: Silencing Id-1 inhibits lymphangiogenesis
through down-regulation of VEGF-C in oral squamous cell carcinoma.
Oral Oncol. 47:27–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiao F, Qiu H, Cui H, Ni X, Li J, Liao W,
Lu L and Ding K: MicroRNA-885-3p inhibits the growth of HT-29 colon
cancer cell xenografts by disrupting angiogenesis via targeting
BMPR1A and blocking BMP/Smad/Id1 signaling. Oncogene. 34:1968–1978.
2015. View Article : Google Scholar : PubMed/NCBI
|
